Quantinno Capital Management’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.84M Buy
142,993
+61,397
+75% +$1.31M ﹤0.01% 1893
2026
Q2
$2.36M Buy
81,596
+43,809
+116% +$1.18M ﹤0.01% 1835
2026
Q1
$684K Buy
+37,787
New +$720K ﹤0.01% 2476
2025
Q4
– Sell
-12,388
Closed -$404K – 3194
2025
Q3
$404K Buy
12,388
+1,628
+15% +$60.1K ﹤0.01% 2206
2025
Q2
$382K Sell
10,760
-324
-3% -$10.5K ﹤0.01% 1840
2025
Q1
$376K Buy
+11,084
New +$398K ﹤0.01% 1507

Other funds holding LEGN

Quantinno Capital Management's LEGN Position: Q3 2026 in Review

Quantinno Capital Management increased its Legend Biotech (LEGN) stake by 75% in Q3 2026, buying an estimated $1.31M and bringing the position to 142,993 shares worth $2.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1893.

Quantinno Capital Management first reported a position in LEGN in Q1 2025 and has held it in 6 quarters since. 197 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • Quantinno Capital Management held 142,993 shares of Legend Biotech worth $2.84M as of Q3 2026.
  • Quantinno Capital Management bought 61,397 Legend Biotech shares in Q3 2026, an estimated $1.31M.
  • Legend Biotech made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1893 holding.
  • Quantinno Capital Management first reported a position in Legend Biotech in Q1 2025 and has held it in 6 quarters since.
  • 197 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.